Different binding modes of structurally diverse ligands for human D3DAR.

Area of Science:

• Pharmacology
• Computational Chemistry
• Structural Biology

Background:

• The dopamine D3 receptor (D3DAR) is a key target for neurological disorders.
• Lack of experimental data necessitates computational approaches for understanding D3DAR ligand interactions.
• Variability in ligand scaffolds and sizes complicates D3DAR model development.

Purpose of the Study:

• To create and validate computational models for the dopamine D3 receptor (D3DAR).
• To build a 3D quantitative structure-activity relationship (QSAR) model for D3DAR antagonists and partial agonists.
• To identify critical ligand properties and receptor residues influencing D3DAR activity.

Main Methods:

• Generation of five distinct D3DAR models based on proposed binding modes.
• Utilizing 114 potent and selective D3DAR antagonists/partial agonists for model discrimination.
• Development of a docking-based 3D QSAR model.

Main Results:

• Successfully discriminated the most reliable D3DAR receptor model.
• Established a 3D QSAR model with good quantitative correlation to ligand activity.
• Identified key ligand properties and receptor residues crucial for D3DAR binding.

Conclusions:

• The developed D3DAR model effectively discriminates binding modes across different ligand classes.
• The model shows strong predictive power for D3DAR antagonist and partial agonist activity.
• This validated D3DAR model is suitable for screening novel drug lead compounds.